ENTMAB 001
Alternative Names: ENTMAB-001Latest Information Update: 30 Aug 2024
At a glance
- Originator Aegis Life
- Class Antimalarials; Antivirals; DNA; Monoclonal antibodies
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical HIV infections; Malaria
Most Recent Events
- 30 Aug 2024 Preclinical trials in HIV infections in USA (IM),prior to August 2024 (Entos Pharmaceuticals pipeline, August 2024)
- 30 Aug 2024 Preclinical trials in Malaria in USA (IM), prior to August 2024 (Entos Pharmaceuticals pipeline, August 2024)
- 19 Mar 2024 Early research in HIV infections in USA (IM)